Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, United States
Coleman K Baker
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, United States
Pei-Yong Shi
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, United States; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, United States; Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, United States; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, United States; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, United States
Shannan L Rossi
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, United States; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, United States; Department of Pathology, University of Texas Medical Branch, Galveston, United States; Center for Biodefense & Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, United States
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, United States; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, United States; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, United States; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, United States; Center for Biodefense & Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, United States
Subgenomic flaviviral RNA (sfRNA) accumulates during infection due to incomplete degradation of viral genomes and interacts with cellular proteins to promote infection. Here we identify host proteins that bind the Zika virus (ZIKV) sfRNA. We identified fragile X mental retardation protein (FMRP) as a ZIKV sfRNA-binding protein and confirmed this interaction in cultured cells and mouse testes. Depletion of FMRP elevated viral translation and enhanced ZIKV infection, indicating that FMRP is a ZIKV restriction factor. We further observed that an attenuated ZIKV strain compromised for sfRNA production was disproportionately stimulated by FMRP knockdown, suggesting that ZIKV sfRNA antagonizes FMRP activity. Importantly, ZIKV infection and expression of ZIKV sfRNA upregulated endogenous FMRP target genes in cell culture and ZIKV-infected mice. Together, our observations identify FMRP as a ZIKV restriction factor whose activity is antagonized by the sfRNA. Interaction between ZIKV and FMRP has significant implications for the pathogenesis of ZIKV infections.